BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gilmore TD. NF-κB and Human Cancer: What Have We Learned over the Past 35 Years? Biomedicines 2021;9:889. [PMID: 34440093 DOI: 10.3390/biomedicines9080889] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun Y, Li N, Cai Y, Zhao X, Yang H. The polymethoxylated flavone hexamethylquercetagetin suppresses NF-κB signaling and inhibits cell survival in cervical carcinoma. Growth Factors 2022. [DOI: 10.1080/08977194.2022.2144282] [Reference Citation Analysis]
2 Sirinian C, Papanastasiou AD, Karayel O, Degn SE, Peroukidis S, Chaniotis D, Nonni A, Repanti M, Kriegsmann M, Makatsoris T, Koutras A, Mann M, Kalofonos HP. Analysis of RANK-c interaction partners identifies TRAF3 as a critical regulator of breast cancer aggressiveness. Neoplasia 2022;33:100836. [PMID: 36095928 DOI: 10.1016/j.neo.2022.100836] [Reference Citation Analysis]
3 Guo H, Zheng L, Guo Y, Han L, Yu J, Lai F. Curculigoside Represses the Proliferation and Metastasis of Osteosarcoma via the JAK/STAT and NF-κB Signaling Pathways. Biol Pharm Bull 2022;45:1466-75. [PMID: 36184504 DOI: 10.1248/bpb.b22-00311] [Reference Citation Analysis]
4 Mirzaei S, Saghari S, Bassiri F, Raesi R, Zarrabi A, Hushmandi K, Sethi G, Tergaonkar V. NF-κB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition. J Cell Physiol 2022. [PMID: 35561232 DOI: 10.1002/jcp.30759] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
5 Rah B, Rather RA, Bhat GR, Baba AB, Mushtaq I, Farooq M, Yousuf T, Dar SB, Parveen S, Hassan R, Mohammad F, Qassim I, Bhat A, Ali S, Zargar MH, Afroze D. JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies. Front Pharmacol 2022;13:821344. [DOI: 10.3389/fphar.2022.821344] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
6 Safdar M, Ozaslan M. Enhanced Catalytic, Antibacterial and Anti-cancer Activities of Erythromycin Capped Gold Nanoparticles. J Inorg Organomet Polym. [DOI: 10.1007/s10904-022-02239-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Zhang T, Ma C, Zhang Z, Zhang H, Hu H. NF-κB signaling in inflammation and cancer. MedComm (2020) 2021;2:618-53. [PMID: 34977871 DOI: 10.1002/mco2.104] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
8 Gilmore TD, Siggers T. Cellular Immunology: Transcriptional Basis of B and T Cell Lineages and Memory Cells − NF-kappaB and the Immune System. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00009-2] [Reference Citation Analysis]
9 Lamas NJ, Martel A, Nahon-Estève S, Goffinet S, Macocco A, Bertolotto C, Lassalle S, Hofman P. Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions. Cancers (Basel) 2021;14:96. [PMID: 35008260 DOI: 10.3390/cancers14010096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
10 El Yaagoubi OM, Oularbi L, Bouyahya A, Samaki H, El Antri S, Aboudkhil S. The role of the ubiquitin-proteasome pathway in skin cancer development: 26S proteasome-activated NF-κB signal transduction. Cancer Biol Ther 2021;:1-14. [PMID: 34583610 DOI: 10.1080/15384047.2021.1978785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bailly C. Anticancer Targets and Signaling Pathways Activated by Britannin and Related Pseudoguaianolide Sesquiterpene Lactones. Biomedicines 2021;9:1325. [PMID: 34680439 DOI: 10.3390/biomedicines9101325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]